Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 116.6
2 %
$ 145 B
Market Cap
25.29
P/E
GILD - COST OF REVENUE
Cost of Revenue GILD - Gilead Sciences, Inc.
28.7 B
LAST VALUE
125.15%
2 YEAR CAGR
43.73%
5 YEAR CAGR
22.44%
10 YEAR CAGR